TSHA position history
The shares of Taysha Gene Therapies (TSHA) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q2: 2,250,000 shares, $15M, 0.07% of portfolio, New
- 2026 Q3: 2,249,000 shares, $11M, 0.05% of portfolio, Reduce 0.0%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|